The Buzz, Issue #13 is now out! This month’s publications look at peanut cross-contamination rates, the safety of second SARS-CoV-2 vaccine doses following an immediate allergic reaction to dose 1, the risk of thyroid autoimmunity in the setting of chronic urticaria, a review of cannabis-related allergy, and another scoping review about culprit drug identification.

~ hivecanada

The Buzz Issue #13, May 2022 edition, will be sent to all HIVE members by email on Mon, May 2nd, and can be accessed online here.

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz